1. Home
  2. EVER vs NBTX Comparison

EVER vs NBTX Comparison

Compare EVER & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

HOLD

Current Price

$16.49

Market Cap

929.5M

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$33.07

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVER
NBTX
Founded
2008
2003
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.5M
1.0B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
EVER
NBTX
Price
$16.49
$33.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$27.00
$26.00
AVG Volume (30 Days)
1.1M
39.7K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
198.86
N/A
EPS
2.63
N/A
Revenue
$163,349,000.00
N/A
Revenue This Year
$14.68
N/A
Revenue Next Year
$11.86
$11.73
P/E Ratio
$6.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.93
$2.99
52 Week High
$30.03
$41.89

Technical Indicators

Market Signals
Indicator
EVER
NBTX
Relative Strength Index (RSI) 44.34 57.18
Support Level $13.93 $20.11
Resistance Level $17.59 N/A
Average True Range (ATR) 0.83 2.69
MACD 0.35 0.03
Stochastic Oscillator 64.55 47.72

Price Performance

Historical Comparison
EVER
NBTX

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: